Studies related to Cognition and Sarcosine

A Randomized, Double-blind, Placebo-controlled Comparison Study Of Sarcosine (N-methylglycine) And D-serine Add-on Treatment For Schizophrenia

Effect Increase
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 60
Sex Both Genders
Age Range 30-44, 45-64
Notes for this study:
Sarcosine at 2,000mg daily for 6 weeks in persons with schizophrenia on stable antipsychotic therapy was able to reduce symptoms of schizophrenia (positive, negative, and cognitive) while the comparator of D-serine at the same dose was ineffective.

Full details on all 2 studies are available to Examine Plus members.

Already a member? Login now to access.